Stocks Poised for +500% by 2030: 268 Replies, No Consensus

Which Stock Will Rise +500% by 2030: 268 Bets, Zero Certainty

Is there a single stock capable of sens an investment before 2030? This question, posted on a financial forum, has gathered 268 replies over 496 days without yielding a definitive answer. The discussion started with BYD, the Chinese electric vehicle manufacturer, championed as the clearest bet by those who argue they are "conquering and innovating the automotive industry." From there, the scope expanded to artificial intelligence, defense, cryptocurrencies, and even iodine.

What stands out is not the list of candidates, but the divide between those who believe a winning company can be identified and those who argue the entire premise is flawed. In between lie specific data points: €75,000 positions, 26% gains in a single session, comparative market caps, and warnings about a bubble that several analyses claim is already underway.

From BYD to AI: Mapping the Bets

The debate began in the automotive sector. BYD attracted early support, with arguments that the Chinese firm is disrupting the market. One participant claims to have €75,000 invested in the stock and deleted their broker app to avoid selling before 2030. User experience reinforces this thesis: someone who bought a BYD in 2014 describes it as a poor car; someone who did so in 2024 notes an abysmal difference.

Artificial intelligence soon emerged as the second major theme. NVIDIA appears as the obvious candidate—more AI means more chips—with some projecting a +300% gain by 2030. AMD enters the conversation with a relative value argument: less than fifteen times its competitor's market cap and a +25% rise in a single day. BigBear, IonQ, Aurora, RocketLab, Alphabet, and even Moderna round out the proposed names.

The Haystack Thesis: Why Buying One Stock Is the Mistake

The most repeated objection doesn't dispute which company will rise, but the logic of seeking just one. "Don't look for the needle in the haystack; buy the haystack," summarizes one intervention proposing simultaneous entry into the forty companies with the highest probability. The reasoning is mathematical: picking the winner among hundreds is improbable, but an aggregate +300% portfolio return is achievable if a single position multiplies by fifteen.

The full calculation, broken down position by position, is the kind of material that only appears when someone seriously crunches numbers. Most interventions, however, are personal bets without development: Tubacex, Nagarro, Janus Electric, Eolo Toys, Chainlink, or a junior rare earth mining company. Each with its story, few with figures.

The Bubble Some See, Others Deny

Warnings run through the thread from start to finish. "A bubble is brewing," argues one side, cautioning that AI will cause both surges and bankruptcies, with unclear winners and losers. Another analysis goes further: it claims the economic blow has already occurred, but the morphine of liquidity injected during the pandemic—near 30% of the existing money supply—prevents people from noticing. That money allegedly flowed into seven listed companies, gold, and cryptocurrencies.

On the other hand, those who believe the cycle continues point to defense stocks, supported by future order books in the arms industry, citing Rheinmetall, Northrop Grumman, and L3Harris. They argue that black swan events are hedged with gold or defense. The discussion drifted toward whether this answers the original question—sens money—or simply avoids losses.

The China Pivot: From Opportunity to Warning

The conversation about China shifted over time. What began as enthusiasm for BYD ended with a harsh warning: anyone who hasn't visited the country doesn't understand how it works, and investing there requires insider information from the party or being Chinese. The memory of NIO, the "Chinese Tesla" that seemed unstoppable in 2020 before collapsing, looms over the initial thesis.

BYD illustrates this tension. Against the long-term investor's enthusiasm, another participant recalls that the stock has lost 50% since a previous comment in the same thread. The gap between narrative and price, in a supposed winner, is exactly the problem nobody solves.

Health, Crypto, and Iodine: The Rest of the Menu

There was room for unconventional bets. A participant who visits hospitals daily backs pharmaceuticals: "it's all full of heart attacks, strokes, and cancers." The reply is cynical yet accurate: the company that cures wins once; the one that chronicizes wins every day. Chainlink is defended as real, operational infrastructure within the crypto ecosystem, integrated by major banks and global payment networks. Someone else proposes, without further detail, any company producing iodine.

The Core Problem: Nobody Knows What Happens in 2030

The conclusion emerging from 268 replies is uncomfortable. There is no consensus on the company, the sector, or even whether the question makes sense. The only recurring theme is the warning that the inflection point—monetary, technological, or geopolitical—will arrive before 2030 and change the rules. Those who have the answer and don't share it are doing well.